Sources Pertaining to Martin Shkreli

Complete Source List used to gather information on

Pharmaceutical Mogul Martin Shkreli


  • Johnson, Carolyn Y. "How Pharma Bro Martin Shkreli Described His Own Drug Price Hike: 'Almost All of It Is Profit.'" Washington Post. The Washington Post, 2 Feb. 2016. Web. 18 Mar. 2016. <https://www.washingtonpost.com/news/wonk/wp/2016/02/02/how-pharma-bro-martin-shkreli-described-his-own-drug-price-hike-almost-all-of-it-is-profit/>.
  • Merle, Renae, and Carolyn Y. Johnson. "Martin Shkreli, Face of a New Economy, Charged with an Old-school Crime." Washington Post. The Washington Post, 17 Dec. 2015. Web. 18 Mar. 2016. <https://www.washingtonpost.com/business/economy/martin-shkreli-face-of-a-new-economy-charged-with-an-old-school-crime/2015/12/17/5df8de3c-a4ee-11e5-ad3f-991ce3374e23_story.html?tid=a_inl>.
  • Mangan, Dan. "Shkreli Attorney: I Told Him to Stop Talking." CNBC. N.p., 03 Feb. 2016. Web. 18 Mar. 2016. <http://www.cnbc.com/2016/02/03/martin-shkrelis-day-in-brooklyn-court.html>.
  • Calderwood, Stephen B. "Letter Regarding the Price Increase for Daraprim." Letter to Tom Evegan & Kevin Bernier. 8 Sept. 2015. N.p., n.d. Web. <http://www.hivma.org/uploadedFiles/HIVMA/HomePageContent/PyrimethamineLetterFINAL.pdf>.
  • Mohney, Gillian. "Company Will Lower Drug Price After Critics Called 4,000% Hike 'Unjustifiable'" ABC News. ABC News Network, 22 Sept. 2015. Web. 18 Mar. 2016. <http://abcnews.go.com/Health/company-lower-drug-price-critics-called-4000-hike/story?id=33955820>.
  • "Former Hedge Fund Manager And New York Attorney Indicted In Multimillion Dollar Fraud Scheme." Justice.gov. United States Department of Justice, 17 Dec. 2015. Web. 19 Mar. 2016. <https://www.justice.gov/usao-edny/pr/former-hedge-fund-manager-and-new-york-attorney-indicted-multimillion-dollar-fraud>.
  • Luckerson, Victor. "Everything to Know About the Arrested Drug Price-Hiking CEO." Time. Time, 18 Dec. 2015. Web. 19 Mar. 2016. <http://time.com/4153512/martin-shkreli-pharmaceuticals-arrested-turing-daraprim/>.
  • Weintraub, Arlene. "Retrophin Sues Founder Martin Shkreli For $65M. His Reply: 'Preposterous'" Forbes. Forbes Magazine, 18 Aug. 2015. Web. 19 Mar. 2016. <http://www.forbes.com/sites/arleneweintraub/2015/08/18/retrophin-sues-founder-martin-shkreli-for-65m-his-reply-preposterous/#1fcd8a0820d1>.
  • Calderwood, Stephen B. "Letter Regarding the Price Increase for Daraprim." Letter to Tom Evegan & Kevin Bernier. 8 Sept. 2015. N.p., n.d. Web. <http://www.hivma.org/uploadedFiles/HIVMA/HomePageContent/PyrimethamineLetterFINAL.pdf>.
  • Pollack, Andrew. "Drug Goes From $13.50 a Tablet to $750, Overnight." The New York Times. The New York Times, 20 Sept. 2015. Web. 28 Mar. 2016. <http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html?_r=0>.
  • "Martin Shkreli." Wikipedia. Wikimedia Foundation, n.d. Web. 28 Mar. 2016. <https://en.wikipedia.org/wiki/Martin_Shkreli>.
  • "Pharma Jackass Wants to Buy Kanye’s New Album for $10M." New York Post. Fox News, 12 Feb. 2016. Web. 28 Mar. 2016. <http://nypost.com/2016/02/12/pharma-jackass-wants-to-buy-kanyes-new-album-for-10m/>.
  • Perez, Chris. "Smirky Martin Shkreli Silent as Lawmakers Rip Him." New York Post. N.p., 04 Feb. 2016. Web. 28 Mar. 2016. <http://nypost.com/2016/02/04/smirky-martin-shkreli-silent-as-lawmakers-rip-him/>.
  • Goldberg, Haley. "Everything You Wanted to Know about Martin Shkreli’s $120 Cup of Tea." New York Post. N.p., 07 Jan. 2016. Web. 28 Mar. 2016. <http://nypost.com/2016/01/07/everything-you-wanted-to-know-about-the-pharma-jackasss-120-cup-of-tea/>.
  • Strum, Beckie. "Creep CEO Martin Shkreli’s Social Media Gets Hacked." New York Post. N.p., 20 Dec. 2015. Web. 28 Mar. 2016. <http://nypost.com/2015/12/20/creep-ceo-martin-shkrelis-social-media-gets-hacked/>.
  • Court, Emma. "Martin Shkreli Really Is a Bad Boy of Pharma, Government Argues." MarketWatch. N.p., 19 Feb. 2016. Web. 28 Mar. 2016. <http://www.marketwatch.com/story/martin-shkreli-really-is-a-bad-boy-of-pharma-government-argues-2016-02-19>.
  • Langlois, Shawn. "6 Perfect Roles for Martin Shkreli, Hollywood's next Leading Man." MarketWatch. N.p., 11 Feb. 2016. Web. 28 Mar. 2016. <http://www.marketwatch.com/story/7-perfect-roles-for-martin-shkreli-hollywoods-next-leading-man-2016-02-11>.
  • "Disgraced Drug Exec Martin Shkreli: I'm Not a 'pharma Bro' | Fox News." Fox News. FOX News Network, 18 Jan. 2016. Web. 28 Mar. 2016. <http://www.foxnews.com/us/2016/01/18/disgraced-drug-exec-martin-shkreli-im-not-pharma-bro.html>.
  • "New Lawyer Silences Bad-boy Ex-pharma CEO Martin Shkreli | Fox News."Fox News. FOX News Network, 03 Feb. 2016. Web. 28 Mar. 2016. <http://www.foxnews.com/us/2016/02/03/new-lawyer-silences-bad-boy-ex-pharma-ceo-martin-shkreli.html>.
  • Perrone, Matthew. "Lawmakers Challenge Turing Executives on Drug Price Hikes." ABC News. ABC News Network, 17 Mar. 2016. Web. 28 Mar. 2016. <http://abcnews.go.com/Health/wireStory/lawyer-turing-execs-warned-shkreli-price-hike-37716608>.
  • Siegel, Benjamin, and Mary Bruce. "Former Pharma Big Martin Shkreli Boasted '$1 Bn Here We Come,' Documents Say." ABC News. ABC News Network, 2 Feb. 2016. Web. 28 Mar. 2016. <http://abcnews.go.com/Politics/pharma-big-martin-shkreli-boasted-bn-documents/story?id=36671216>.
  • Mohney, Gillian. "Company Will Lower Drug Price After Critics Called 4,000% Hike 'Unjustifiable'" ABC News. ABC News Network, 22 Sept. 2015. Web. 28 Mar. 2016. <http://abcnews.go.com/Health/company-lower-drug-price-critics-called-4000-hike/story?id=33955820>.
  • Conti, Allie. "Watch: Martin Shkreli on Drug Price Hikes and Playing the World's Villain | VICE | United States." VICE. VICE Media LLC, n.d. Web. 28 Mar. 2016. <https://www.vice.com/video/drinking-wine-and-playing-chess-at-martin-shkrelis-midtown-apartment>.
  • Wilmore, Larry. "Carriage of Justice - Martin Shkreli's Arrest- - Video Clip | Comedy Central." Comedy Central. Viacom, 17 Dec. 2015. Web. 28 Mar. 2016. <http://www.cc.com/video-clips/rmbz03/the-nightly-show-with-larry-wilmore-carriage-of-justice---martin-shkreli-s-arrest>.
  • "Turing Pharmaceuticals CEO Martin Shkreli Defends 5,000 Percent Price Hike on Daraprim." CBSNews. CBS Interactive, 22 Sept. 2015. Web. 28 Mar. 2016. <http://www.cbsnews.com/news/turing-pharmaceuticals-ceo-martin-shkreli-defends-5000-percent-price-hike-on-daraprim-drug/>.
  • "Meet the Moneyman behind a Controversial Prescription Price Hike."CBSNews. CBS Interactive, 22 Sept. 2015. Web. 28 Mar. 2016. <http://www.cbsnews.com/news/martin-shkreli-meet-the-moneyman-behind-a-controversial-prescription-price-hike/>.
  • Gibson, Katie. "Even Muzzled, Martin Shkreli Still Annoys Lawmakers."CBSNews. CBS Interactive, 4 Feb. 2016. Web. 28 Mar. 2016. <http://www.cbsnews.com/news/a-muzzled-martin-shkreli-taken-to-task-by-lawmakers/>.
  • McClean, Robert. "Martin Shkreli on Drug Price Hike: '$1 Billion Here We Come'" CNNMoney. Cable News Network, 3 Feb. 2016. Web. 28 Mar. 2016. <http://money.cnn.com/2016/02/03/news/shkreli-turing-daraprim-price-house-hearing/>.
  • Torgerson, Paul R., and Pierpaolo Mastroiacovo. "Diagnosing Congenital Toxoplasmosis: Where Are We? A Systematic Review." Int Arch Med International Archives of Medicine (2015): 501-08. World Health Organization, 2013 July 1. Web. 28 Mar. 2016. <http://www.who.int/bulletin/volumes/91/7/12-111732.pdf>.
  • "Martin Shkreli's Many Faces Say More than Words." CNNMoney. Cable News Network, n.d. Web. 28 Mar. 2016. <http://money.cnn.com/video/news/2016/02/04/shkreli-hearing.cnnmoney>.
  • Abdullah, Halimah. "'Pharma Bro' Martin Shkreli Invokes the Fifth Before Congress." NBC News. Comcast, 4 Feb. 2016. Web. 28 Mar. 2016. <http://www.nbcnews.com/news/us-news/pharma-bro-martin-shkreli-faces-congress-n511106>..
  • Ortiz, Erik, Johnathan Dientz, Joe Valiquette, and Alicia Hastey. "FBI Arrests Pharma CEO Martin Shkreli on Securities Fraud Charges." NBC News. Comcast, 17 Dec. 2015. Web. 28 Mar. 2016. <http://www.nbcnews.com/business/business-news/fbi-arrests-controversial-turing-pharmaceuticals-ceo-martin-shkreli-report-n481671>.
  • "Gertrude B. Elion - Biographical". Nobelprize.org. Nobel Media AB 2014. Web. 27 Mar 2016. <http://www.nobelprize.org/nobel_prizes/medicine/laureates/1988/elion-bio.html>
  • Zheng, W., H. Jiang, Z. Xiong, Z. Jiang, and H. Chen. "Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years."Iranian Journal of Parasitology. Tehran University of Medical Sciences, Winter 2013. Web. 28 Mar. 2016. <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655235/>.
  • Eyles, DE, and N. Coleman. "Synergistic Effect of Sulfadiazine and Daraprim against Experimental Toxoplasmosis in the Mouse." National Center for Biotechnology Information. U.S. National Library of Medicine, 3 May 1953. Web. 28 Mar. 2016. <http://www.ncbi.nlm.nih.gov/pubmed/24542412>.
  • "Turing Pharmaceuticals CEO Martin Shkreli Defends 5,000 Percent Price Hike on Daraprim." CBSNews. CBS Interactive, 22 Sept. 2015. Web. 28 Mar. 2016. <http://www.cbsnews.com/news/turing-pharmaceuticals-ceo-martin-shkreli-defends-5000-percent-price-hike-on-daraprim-drug/>.
  • KAUFMAN HE, REMINGTON J, MELTON ML, JACOBS L. Relative Resistance of Slow-Growing Strains of Toxoplasma Gondii to Pyrimethamine (Daraprim). AMA Arch Ophthalmol. 1959;62(4):611-615. doi:10.1001/archopht.1959.04220040073010
  • Huber, W., W. Bautz, M. Classen, and W. Schepp. "[Pyrimethamine-sulfadiazine Resistant Cerebral Toxoplasmosis in AIDS]." National Center for Biotechnology Information. U.S. National Library of Medicine, 5 Jan. 1995. Web. 28 Mar. 2016. <http://www.ncbi.nlm.nih.gov/pubmed/7828463>.
  • Katlama, C., S. De Wit, E. O'Doherty, M. Van Glabeke, and N. Clumeck. "Pyrimethamine-clindamycin vs. Pyrimethamine-sulfadiazine as Acute and Long-term Therapy for Toxoplasmic Encephalitis in Patients with AIDS." National Center for Biotechnology Information. U.S. National Library of Medicine, 1996. Web. 28 Mar. 2016. <http://www.ncbi.nlm.nih.gov/pubmed/8838183>.
  • Pollack, Andrew. "Drug Goes From $13.50 a Tablet to $750, Overnight." The New York Times. The New York Times, 20 Sept. 2015. Web. 28 Mar. 2016. <http://www.nytimes.com/2015/09/21/business/a-huge-overnight-increase-in-a-drugs-price-raises-protests.html>.
  • Silverman, Ed. "What Does It Cost to Develop a New Drug? Latest Study Says $2.6 Billion." WSJ. Dow Jones & Company, Inc., 20 Nov. 2014. Web. 28 Mar. 2016. <http://www.wsj.com/articles/what-does-it-cost-to-develop-a-new-drug-latest-study-says-2-6-billion-1416529149>.
  • Herper, Matthew. "The Cost Of Creating A New Drug Now $5 Billion, Pushing Big Pharma To Change." Forbes. Forbes Magazine, 11 Aug. 2013. Web. 28 Mar. 2016. <http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/#6214a8236bfc>.
  • "10 Wildly Overinflated Hospital Costs | Reader's Digest." Readers Digest. Trusted Media Brands, Inc., n.d. Web. 28 Mar. 2016. <http://www.rd.com/health/wellness/wildly-overinflated-hospital-costs/>.
  • Rosenthal, Elisabeth. "As Hospital Prices Soar, a Stitch Tops $500." The New York Times. The New York Times, 02 Dec. 2013. Web. 28 Mar. 2016. <http://www.nytimes.com/2013/12/03/health/as-hospital-costs-soar-single-stitch-tops-500.html>.
  • Turing Pharmaceutical's Official Website for Daraprim <http://www.daraprimdirect.com/patients>.
  • "AHF: $750 Drug That Sells For $1 to Government Agencies Underscores Need for Drug Pricing Reform." BusinessWire. BusinessWire, 24 Sept. 2015. Web. 28 Mar. 2016. <http://www.businesswire.com/news/home/20150924006206/en/AHF-750-Drug-Sells-1-Government-Agencies>.
  • Walters, Joanna. "Martin Shkreli: Entrepreneur Defends Decision to Raise Price of Life-saving Drug 50-fold." The Guardian. Guardian News and Media, 22 Sept. 2015. Web. 28 Mar. 2016. <http://www.theguardian.com/business/2015/sep/21/entrepreneur-defends-raise-price-daraprim-drug>.
  • Nather, David. "Documents: Officers at Shkreli's Company Received Huge Raises." STAT. Stat News, 04 Feb. 2016. Web. 28 Mar. 2016. <http://www.statnews.com/2016/02/04/chaffetz-turing-shkreli-profit/>.
  • Garde, Damian. "Shkreli's Turing Pharma Banks $90M in a Murky Funding round." FierceBiotech. FierceMarkets, 10 Aug. 2015. Web. 28 Mar. 2016. <http://www.fiercebiotech.com/story/shkrelis-turing-pharma-banks-90m-murky-funding-round/2015-08-10>.
  • "Compensation Information for Martin Shkreli , Former Chief Executive Officer of RETROPHIN INC | Salary.com." Salary.com. Salary.com, Inc., n.d. Web. 28 Mar. 2016. <http://www1.salary.com/Martin-Shkreli-Salary-Bonus-Stock-Options-for-RETROPHIN-INC.html>.
  • Reuters. "Martin Shkreli's E*Trade Account Has Lost $40 Million." Fortune Martin Shkrelis ETrade Account Has Lost 40 Million Comments. Time Inc., 03 Feb. 2016. Web. 28 Mar. 2016. <http://fortune.com/2016/02/03/martin-shkrelis-etrade-account-has-lost-40-million/>.

No comments:

Post a Comment

Subscribe to: Posts (Atom)